Lafayette Investments, Inc. Rani Therapeutics Holdings, Inc. Call Options Transaction History
Lafayette Investments, Inc.
- $482 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
45Shares Held
6.28MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$1.45 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA800KShares$367,8520.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$227,0480.48% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$139,2610.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$87,6560.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $11.3M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...